0001104659-16-135018.txt : 20160728
0001104659-16-135018.hdr.sgml : 20160728
20160728162126
ACCESSION NUMBER: 0001104659-16-135018
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20160630
FILED AS OF DATE: 20160728
DATE AS OF CHANGE: 20160728
EFFECTIVENESS DATE: 20160728
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Versant Venture Management, LLC
CENTRAL INDEX KEY: 0001560009
IRS NUMBER: 954767945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16849
FILM NUMBER: 161790424
BUSINESS ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
BUSINESS PHONE: 650-233-7877
MAIL ADDRESS:
STREET 1: ONE SANSOME STREET, SUITE 3630
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94104
13F-HR
1
primary_doc.xml
13F-HR
LIVE
0001560009
XXXXXXXX
06-30-2016
06-30-2016
false
Versant Venture Management, LLC
One Sansome Street, Suite 3630
San Francisco
CA
94104
13F HOLDINGS REPORT
028-16849
N
Robin L. Praeger
Managing Director, Versant Venture Management, LLC
415-801-8100
/s/ Robin L. Praeger
San Francisco
CA
07-26-2016
0
5
98672513
false
INFORMATION TABLE
2
a16-15564_1informationtable.xml
INFORMATION TABLE
Clovis Oncology, Inc.
Common Stock
189464100
5589748
407416
SH
OTR
0
407416
0
CymaBay Therapeutics, Inc.
Common Stock
23257D103
1824566
1048601
SH
OTR
0
1048601
0
Achaogen, Inc.
Common Stock
004449104
4855566
1281152
SH
OTR
0
1281152
0
Ocular Therapeutix, Inc.
Common Stock
67576A100
10966151
2215384
SH
OTR
0
2215384
0
Glaukos Corporation
Common Stock
377322102
75436483
2586985
SH
OTR
0
2586985
0